Anthem Biosciences Limited (NSE:ANTHEM)
India
· Delayed Price · Currency is INR 773.50
-0.80 (-0.10%)
Apr 29, 2026, 2:15 PM IST
Anthem Biosciences Market Cap
Anthem Biosciences has a market cap or net worth of 434.85 billion as of April 28, 2026.
Market Cap
434.85B
Enterprise Value
425.64B
Revenue
20.02B
Ranking
n/a
PE Ratio
90.28
Stock Price
773.50
Market Cap Chart
Since July 21, 2025, Anthem Biosciences's market cap has increased from 410.17B to 434.85B, an increase of 6.02%. That is a compound annual growth rate of 7.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 434.85B | 18.85% |
| Dec 31, 2025 | 365.89B | -10.80% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 587.14B |
| OneSource Specialty Pharma | 202.11B |
| Concord Biotech | 112.15B |
| Blue Jet Healthcare | 76.96B |
| Supriya Lifescience | 56.72B |
| Zota Health Care | 44.01B |
| Dishman Carbogen Amcis | 28.87B |
| Panacea Biotec | 22.59B |